Department of Internal Medicine, Kaohsiung Veterans General Hospital, Taiwan.
J Clin Gastroenterol. 2009 Nov-Dec;43(10):941-5. doi: 10.1097/MCG.0b013e31819c3885.
Endoscopic treatment is recommended for initial hemostasis in nonvariceal upper gastrointestinal bleeding. Many endoscopic devices have been demonstrated to be effective in the hemostasis of bleeding ulcers. However, the hemostatic efficacy of argon plasma coagulation (APC) has not been widely investigated.
From February 2007 to February 2008, 271 consecutive patients with high-risk bleeding ulcers, characterized by active bleeding, nonbleeding visible vessels and adherent clots, were admitted to our hospital. Among these patients, 135 nonrandomly underwent either APC therapy or distilled water injection. Pantoprazole infusion was conducted during the fasting period after endoscopy and orally for 8 weeks to encourage ulcer healing. Episodes of rebleeding were retreated with endoscopic combination therapy. Patients who did not benefit from retreatment underwent emergency surgery.
In all,135 patients were enrolled, among whom 6 with gastric malignancy, acute severe illness or multiple bleeding sites were excluded. Finally, hemostatic efficacy in 59 patients treated with APC was prospectively compared with 70 patients treated with distilled water injection. The two treatment groups were similar with respect to all baseline characteristics. Initial hemostasis was accomplished in 57 patients treated with APC, and 64 patients with distilled water injection therapy (97% vs. 91%, P=0.29). Bleeding recurred in 6 patients treated with APC, and in 17 patients treated with distilled water injection (11% vs. 27%, P=0.03). No significant differences were observed between the 2 groups in hospital stay, transfusion requirements, surgery and mortality.
Endoscopic therapy with APC is more effective than distilled water injection for preventing rebleeding in the treatment of high-risk bleeding ulcers.
内镜治疗被推荐用于非静脉曲张性上消化道出血的初始止血。许多内镜设备已被证明在止血溃疡方面有效。然而,氩等离子凝固(APC)的止血效果尚未得到广泛研究。
2007 年 2 月至 2008 年 2 月,我院收治了 271 例高危出血性溃疡患者,其特征为活动性出血、非出血可见血管和黏附性血栓。这些患者中,135 例非随机接受 APC 治疗或蒸馏水注射。内镜检查后禁食期间给予泮托拉唑输注,并口服 8 周以促进溃疡愈合。再出血发作采用内镜联合治疗。未从再治疗中获益的患者接受紧急手术。
共纳入 135 例患者,其中 6 例因胃恶性肿瘤、急性严重疾病或多处出血部位而被排除。最终,前瞻性比较了 59 例接受 APC 治疗的患者和 70 例接受蒸馏水注射治疗的患者的止血效果。两组患者在所有基线特征方面均相似。接受 APC 治疗的 57 例患者初始止血成功,接受蒸馏水注射治疗的 64 例患者初始止血成功(97% vs. 91%,P=0.29)。接受 APC 治疗的 6 例患者发生再出血,接受蒸馏水注射治疗的 17 例患者发生再出血(11% vs. 27%,P=0.03)。两组患者在住院时间、输血需求、手术和死亡率方面无显著差异。
内镜治疗 APC 比蒸馏水注射更能有效预防高危出血性溃疡再出血。